Literature DB >> 28673608

Mitochondrial biology in cancer stem cells.

Rute Loureiro1, Katia A Mesquita2, Silvia Magalhães-Novais2, Paulo J Oliveira2, Ignacio Vega-Naredo3.   

Abstract

Cancer stem cells (CSCs) have been suggested to be responsible for tumor re-growth and relapse. Physiological and morphological knowledge of CSCs may be essential for the development of new therapeutic strategies targeting cancer development, progression, and recurrence. Current research is focused on a deeper understanding of CSCs metabolic profiles, taking into consideration their energy demands. Energy metabolism and mitochondrial function are important factors operating on stemness maintenance and cell fate specification. Due to the role of mitochondria as central hubs in the overall cell metabolism and death and survival pathways, research on their physiology in CSCs is of paramount importance to decipher mechanisms underlying their therapy-resistant phenotype. In this review, we focus on CSCs mitochondrial biology and mitochondria-related signaling pathways that contribute to CSCs survival and maintenance, thereby representing possible therapeutic targets.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Cell death; Chemotherapy; Metabolism; Mitochondria

Mesh:

Year:  2017        PMID: 28673608     DOI: 10.1016/j.semcancer.2017.06.012

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  14 in total

Review 1.  Mitostemness.

Authors:  Elisabet Cuyàs; Sara Verdura; Núria Folguera-Blasco; Cristian Bastidas-Velez; Ángel G Martin; Tomás Alarcón; Javier A Menendez
Journal:  Cell Cycle       Date:  2018-07-02       Impact factor: 4.534

Review 2.  Roles of mitochondria in liver cancer stem cells.

Authors:  Ching-Wen Chang; Jeng-Fan Lo; Xin Wei Wang
Journal:  Differentiation       Date:  2019-05-30       Impact factor: 3.880

Review 3.  Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases.

Authors:  Amaneh Mohammadi Roushandeh; Yoshikazu Kuwahara; Mehryar Habibi Roudkenar
Journal:  Cytotechnology       Date:  2019-01-31       Impact factor: 2.058

Review 4.  Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer.

Authors:  Thomas C Beadnell; Adam D Scheid; Carolyn J Vivian; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

Review 5.  The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues.

Authors:  Anna Sebestyén; Titanilla Dankó; Dániel Sztankovics; Dorottya Moldvai; Regina Raffay; Catherine Cervi; Ildikó Krencz; Viktória Zsiros; András Jeney; Gábor Petővári
Journal:  Cancer Metastasis Rev       Date:  2022-01-14       Impact factor: 9.264

6.  ALDH1L2 Knockout in U251 Glioblastoma Cells Reduces Tumor Sphere Formation by Increasing Oxidative Stress and Suppressing Methionine Dependency.

Authors:  Maëlle Quéré; Jean-Marc Alberto; Franck Broly; Sébastien Hergalant; Christo Christov; Guillaume Gauchotte; Jean-Louis Guéant; Farès Namour; Shyue-Fang Battaglia-Hsu
Journal:  Nutrients       Date:  2022-04-30       Impact factor: 6.706

7.  Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.

Authors:  Xiaocong Xiang; Rong Xiong; Chunlei Yu; Li Deng; Jun Bie; Dongqin Xiao; Zhu Chen; Yuchuan Zhou; Xiaolei Li; Kang Liu; Gang Feng
Journal:  Oncol Rep       Date:  2019-10-16       Impact factor: 3.906

8.  The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma.

Authors:  Shengchen Lin; Chongbiao Huang; Jianwei Sun; Oana Bollt; Xiuchao Wang; Eric Martine; Jiaxin Kang; Matthew D Taylor; Bin Fang; Pankaj K Singh; John Koomen; Jihui Hao; Shengyu Yang
Journal:  EMBO Mol Med       Date:  2019-10-21       Impact factor: 12.137

Review 9.  Cancer stem cells and strategies for targeted drug delivery.

Authors:  Jin Cao; Shubhmita Bhatnagar; Jiawei Wang; Xueyong Qi; Swayam Prabha; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2020-10-23       Impact factor: 5.671

10.  A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.

Authors:  Federica Sotgia; Bela Ozsvari; Marco Fiorillo; Ernestina Marianna De Francesco; Gloria Bonuccelli; Michael P Lisanti
Journal:  Cell Cycle       Date:  2018-09-26       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.